Evidence map›Paper›PMID 36978430›Full record

ArticleAntibiotics (Basel, Switzerland)2023

Novel Lactotransferrin-Derived Antimicrobial Peptide LF-1 Inhibits the Cariogenic Virulence Factors of

Junyuan Luo, Zening Feng, Xiaohui Lyu, Linglin Zhang

Open access · goldFull text read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Zoliflodacin inhibitsFrontiers in cellular and infection microbiology · 2025
    Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Junyuan LuoDepartment of Endodontics, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, College of Stomatology, Shanghai Jiao Tong University, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology, Shanghai Research Institute of Stomatology, No. 639, Zhizaoju Road, Shanghai 200011, China.
Zening FengDepartment of Endodontics, Shanghai Stomatological Hospital, Fudan University, No. 356, East Beijing Road, Shanghai 200001, China.
Xiaohui LyuState Key Laboratory of Oral Diseases and National Clinical Research Centre for Oral Diseases, Sichuan University, No. 14, Section 3, Renmin Road South, Chengdu 610041, China.
Linglin ZhangState Key Laboratory of Oral Diseases and National Clinical Research Centre for Oral Diseases, Sichuan University, No. 14, Section 3, Renmin Road South, Chengdu 610041, China.
Shanghai Ninth People's Hospital · CNShanghai Stomatological Hospital · CNSichuan University · CNState Key Laboratory of Oral Diseases

Funding

National Natural Science Foundation of China 81771062the Science and Technology Commission of Shanghai Municipality 22Y21901000
6 · The paper itself

Abstract

We previously developed a novel lactotransferrin-derived antimicrobial peptide, LF-1, with selective antibacterial activity against the characteristic cariogenic bacterium

Indexed as

antimicrobial peptidescariogenic virulencedental carieslactotransferrinStreptococcus mutans

Identifiers

PMID36978430
PMCPMC10044700
OpenAlexW4324054491

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read74
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.